These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11996455)

  • 1. Lactulose in the prevention of recurrent urinary tract infection.
    Patial RK
    J Assoc Physicians India; 2001 Dec; 49():1214. PubMed ID: 11996455
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disturbance of liver functions and dysbiosis in patients with lipid distress syndrome and its treatment with lactulose preparation "Duphalac" (lactulose)].
    Petukhov VA; Karalkin AV; Ibragimov TI; Petukhova NA; Briushkov AIu; Vashchenko NE
    Ross Gastroenterol Zh; 2001; (2):92-102. PubMed ID: 11681193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC; Sharma P; Agrawal A; Sarin SK
    Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactulose.
    Nurs Times; 2006 Jan 31-Feb 6; 102(5):31. PubMed ID: 16475577
    [No Abstract]   [Full Text] [Related]  

  • 5. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.
    Kalaitzakis E; Björnsson E
    Hepatology; 2007 Sep; 46(3):949-50; author reply 951. PubMed ID: 17879365
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical efficacy of duphalac in the treatment of functional constipations].
    Shevtsov SA
    Eksp Klin Gastroenterol; 2005; (6):58-60. PubMed ID: 17378389
    [No Abstract]   [Full Text] [Related]  

  • 7. [Constipation in pregnant women - use of Duphalac].
    Damjanov L
    Akush Ginekol (Sofiia); 2002; 41 Suppl 2():27. PubMed ID: 19708192
    [No Abstract]   [Full Text] [Related]  

  • 8. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to dispel myths in the treatment of hepatic encephalopathy?
    Braillon A
    Nat Clin Pract Gastroenterol Hepatol; 2007 Oct; 4(10):E1; author reply E2. PubMed ID: 17909528
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial.
    Montini G; Rigon L; Zucchetta P; Fregonese F; Toffolo A; Gobber D; Cecchin D; Pavanello L; Molinari PP; Maschio F; Zanchetta S; Cassar W; Casadio L; Crivellaro C; Fortunati P; Corsini A; Calderan A; Comacchio S; Tommasi L; Hewitt IK; Da Dalt L; Zacchello G; Dall'Amico R;
    Pediatrics; 2008 Nov; 122(5):1064-71. PubMed ID: 18977988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial.
    Uehling DT; Hopkins WJ; Beierle LM; Kryger JV; Heisey DM
    J Infect Dis; 2001 Mar; 183 Suppl 1():S81-3. PubMed ID: 11171022
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical symptoms predictive of recurrent urinary tract infections.
    Gopal M; Northington G; Arya L
    Am J Obstet Gynecol; 2007 Jul; 197(1):74.e1-4. PubMed ID: 17618765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical value of the correction of disorders of intestinal microcenosis in patients with acid-dependent diseases of the digestive apparatus].
    Tkachenko EI; Uspenskiĭ IuP; Avalueva EB; Zakharchenko MM; Baryshnikova NV
    Eksp Klin Gastroenterol; 2004; (6):52-6. PubMed ID: 16259442
    [No Abstract]   [Full Text] [Related]  

  • 14. [Non-antibiotic prophylaxis for recurrent urinary-tract infections].
    Beerepoot MA; ter Riet G; Verbon A; Nys S; de Reijke TM; Geerlings SE
    Ned Tijdschr Geneeskd; 2006 Mar; 150(10):541-4. PubMed ID: 16566416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy.
    Candy DC; Edwards D; Geraint M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):65-70. PubMed ID: 16819379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of spontaneous bacterial peritonitis by lactulose?].
    Huchzermeyer H; Grünewald T; Schumann C
    Med Klin (Munich); 1999 Nov; 94(11):652. PubMed ID: 10603740
    [No Abstract]   [Full Text] [Related]  

  • 17. Lactulose--a potential drug for the treatment of inflammatory bowel disease.
    Liao W; Cui XS; Jin XY; Florén CH
    Med Hypotheses; 1994 Oct; 43(4):234-8. PubMed ID: 7838007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.
    Hafer A; Krämer S; Duncker S; Krüger M; Manns MP; Bischoff SC
    BMC Gastroenterol; 2007 Sep; 7():36. PubMed ID: 17784949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized crossover trial comparing fibre with lactulose in the treatment of idiopathic chronic constipation.
    Quah HM; Ooi BS; Seow-Choen F; Sng KK; Ho KS
    Tech Coloproctol; 2006 Jul; 10(2):111-4. PubMed ID: 16773290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
    Zeng Z; Li YY
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1126-9. PubMed ID: 12921628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.